We serve Chemical Name:2-methyl-1-oxobenzo[b][1,6]naphthyridine-4-carbaldehyde CAS:88752-82-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![2-methyl-1-oxobenzo[b][1,6]naphthyridine-4-carbaldehyde](https://a.dearchem.com/CAS2/88752-82-3.png)
Chemical Name:2-methyl-1-oxobenzo[b][1,6]naphthyridine-4-carbaldehyde
CAS.NO:88752-82-3
Synonyms:2-methyl-1-oxobenzo[b][1,6]naphthyridine-4-carbaldehyde
Molecular Formula:C14H10N2O2
Molecular Weight:238.24100
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:493ºC at 760 mmHg
Density:1.409g/cm3
Index of Refraction:1.751
PSA:51.96000
Exact Mass:238.07400
LogP:1.89920
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-methyl-1-oxobenzo[b][1,6]naphthyridine-4-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-methyl-1-oxobenzo[b][1,6]naphthyridine-4-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methyl-1-oxobenzo[b][1,6]naphthyridine-4-carbaldehyde Use and application,2-methyl-1-oxobenzo[b][1,6]naphthyridine-4-carbaldehyde technical grade,usp/ep/jp grade.
Related News: Another area AZ sees as a growth opportunity in China is rare diseases. In announcing its recent $39 billion acquisition of Alexion late last year, Soriot highlighted the potential to expand the Boston firm’s rare disease portfolio to China. rel-(1R,3R)-3-butyl-3-methoxy-N,N-dimethylcyclohexan-1-amine manufacturers It’s official. Nearly two years after the FDA granted conditional approval to Merck’s Keytruda and Eisai’s Lenvima for endometrial cancer, the U.S. regulator has blessed the combination therapy, with no strings attached. 3-(4-benzylpiperazin-1-yl)-1-(2-hydroxyphenyl)propan-1-one dihydrochloride suppliers GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said. 4-[1-(Ethoxycarbonyloxy)ethoxy]-2-methyl-N-(5-methyl-3-isoxazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide vendor & factory.
